110 related articles for article (PubMed ID: 28064217)
1. Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer.
Dziggel L; Schild SE; Veninga T; Bajrovic A; Rades D
In Vivo; 2017 Jan; 31(1):35-38. PubMed ID: 28064217
[TBL] [Abstract][Full Text] [Related]
2. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
Rades D; Kueter JD; Meyners T; Pluemer A; Veninga T; Gliemroth J; Schild SE
Clin Neurol Neurosurg; 2012 May; 114(4):326-30. PubMed ID: 22152784
[TBL] [Abstract][Full Text] [Related]
3. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.
Rades D; Veninga T; Hornung D; Wittkugel O; Schild SE; Gliemroth J
Cancer; 2012 Feb; 118(4):1138-44. PubMed ID: 21761403
[TBL] [Abstract][Full Text] [Related]
4. Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain Metastases.
Rades D; Janssen S; Veninga T; Schild SE
Anticancer Res; 2016 Jun; 36(6):3071-4. PubMed ID: 27272829
[TBL] [Abstract][Full Text] [Related]
5. Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer.
Bartscht T; Rades D
Anticancer Res; 2014 Aug; 34(8):4357-60. PubMed ID: 25075071
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
Meyners T; Heisterkamp C; Kueter JD; Veninga T; Stalpers LJ; Schild SE; Rades D
BMC Cancer; 2010 Oct; 10():582. PubMed ID: 20977700
[TBL] [Abstract][Full Text] [Related]
8. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
Rades D; Janssen S; Dziggel L; Blanck O; Bajrovic A; Veninga T; Schild SE
BMC Cancer; 2017 Jan; 17(1):30. PubMed ID: 28061768
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
10. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
11. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
12. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
13. Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers.
Dziggel L; Janssen S; Bajrovic A; Veninga T; Trang NT; Khoa MT; Schild SE; Rades D
Anticancer Res; 2016 Sep; 36(9):4777-80. PubMed ID: 27630327
[TBL] [Abstract][Full Text] [Related]
14. Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.
Rades D; Kueter JD; Gliemroth J; Veninga T; Pluemer A; Schild SE
Strahlenther Onkol; 2012 Feb; 188(2):143-7. PubMed ID: 22234538
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
Rades D; Haatanen T; Schild SE; Dunst J
Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
[TBL] [Abstract][Full Text] [Related]
16. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
17. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.
Rades D; Dziggel L; Janssen S; Khoa MT; Duong VN; Khiem VH; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 Apr; 38(4):2415-2418. PubMed ID: 29599370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
